MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Challenges in the measurement of brain iron deposition in Parkinson’s disease in non-academic research settings.

B. Kashyap, K. Wyman-Chick, L. Hanson, S. Gustafson, S. Sherman, W. Frey, Ii, J. Johnson (St Paul, USA)

Meeting: 2023 International Congress

Abstract Number: 1575

Keywords: Iron, Parkinson’s

Category: Parkinson's Disease: Neuroimaging

Objective: Assess the feasibility of detecting brain iron deposition using quantitative susceptibility mapping (QSM) among patients with Parkinson’s disease (PD) in a community-based clinic setting.

Background: Excessive brain iron accumulation can be found in PD and other neurodegenerative diseases and is thought to enhance free radical formation, contribute to oxidative stress, and result in neuronal death in iron-overloaded cells. Researchers have established brain iron accumulation, as measured by QSM, is associated with cognitive impairment among individuals with PD. Here we report the feasibility of conducting QSM research in a non-academic research center.

Method: We recruited 9 participants with PD from a community-based clinic to undergo neuroimaging, motor examination (UPDRS-III), depression screening, and a brief cognitive battery. Neuroimages were processed utilizing QSM, guided by previously established methods (Table 1). We examined nine different regions of interest (ROI; Table 2). The study team included a movement disorder neurologist, neuropsychologist, biostatistician, and neuroscience research investigators.

Results: The average age of the participants was 69.3 ± 9.7 (77.8% male; UPDRS-III 30.6 ± 8.8; MoCA = 23.0 ± 5.3; GDS 1.8 ± 2.0). Due to motion artifacts, only 3-4 out of the 9 planned ROI were interpretable, including the substantia nigra, globus pallidus, prefrontal cortex, and temporal regions. Table 3 includes QSM data from the substantia nigra and globus pallidus stratified by the participant’s cognitive status. We discovered a lack of standardization in QSM methods across multiple studies, making cross-study comparisons difficult. Key challenges in processing the images included operating system limitations for existing QSM programs (e.g., our healthcare system does not use Linux) and the lack of a radiologist or neuroradiologist on the team (Table 4).

Conclusion: To our knowledge, there are no studies utilizing QSM to identify brain iron deposition in patients with PD in non-academic research settings; however, we identified several barriers to conducting this research. We recommend further standardization of QSM methods and development of programs/algorithms which can be used across multiple operating systems.

Table 1

Table 2

Table 3

To cite this abstract in AMA style:

B. Kashyap, K. Wyman-Chick, L. Hanson, S. Gustafson, S. Sherman, W. Frey, Ii, J. Johnson. Challenges in the measurement of brain iron deposition in Parkinson’s disease in non-academic research settings. [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/challenges-in-the-measurement-of-brain-iron-deposition-in-parkinsons-disease-in-non-academic-research-settings/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/challenges-in-the-measurement-of-brain-iron-deposition-in-parkinsons-disease-in-non-academic-research-settings/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley